Nabekura Tsukasa

Researcher's full information

Conference, etc.
  • A critical role of DNAM-1 in the development of acute graft-versus-host disease
    Nabekura Tsukasa
    The Keystone Symposia on Molecular and Cellular Biology (Lymphocyte Activation)/2010-02
  • Novel prophylactic and therapeutic approaches to GVHD with a monoclonal antibody against DNAM-1
    Nabekura Tsukasa
    The 39th Annual Meeting of the Japanese Society of Immunology/2009-12
  • Novel prophylactic and therapeutic approaches to GVHD with a monoclonal antibody against DNAM-1
    Nabekura Tsukasa
    The 71st Annual Meeting of the Japanese Society of Hematology/2009-10
  • Induction of tumor-specific T cells by inoculation of genetically modified dendritic cells
    Nabekura Tsukasa
    The 18th Kyoto T Cell Conference/2008-06
  • An immunotherapy approach with dendritic cells genetically modified to express the tumor-associated antigen, HER2
    Nabekura Tsukasa
    The 37th Annual Meeting of the Japanese Society of Immunology/2007-11
  • Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
    Nabekura Tsukasa
    The 13th Annual Meeting of the Japan Society of Gene Therapy/2007-06
  • Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
    Nabekura Tsukasa
    The 36th Annual Meeting of the Japanese Society of Immunology/2006-12
  • Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
    Nabekura Tsukasa
    The 12th Annual Meeting of the Japan Society of Gene Therapy/2006-08
  • Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
    Nabekura Tsukasa
    The 35th Annual Meeting of the Japanese Society for Immunology/2005-12
  • Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
    Nabekura Tsukasa
    The 11th Annual Meeting of the Japan Society of Gene Therapy/2005-07
  • Potent cancer immunotherapy with dendritic cells generated from genetically modified hematopoietic stem cells
    Nabekura Tsukasa
    The 7th Annual Meeting of the American Society of Gene Therapy/2004-06
  • Establishment of a novel cancer immunotherapy with genetically modified dendritic cells.
    Nabekura Tsukasa
    The 33rd Annual Meeting of the Japanese Society for Immunology/2003-12